Ganglioside-induced inhibition of in vivo immune response in mice
- 31 December 1992
- journal article
- Published by Elsevier in Life Sciences
- Vol. 51 (11) , 847-851
- https://doi.org/10.1016/0024-3205(92)90612-s
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- Inhibition of Human Immunodeficiency Virus Infection of Human Lymphocytes by GangliosidesJapanese Journal of Cancer Research, 1989
- Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytesBiochemical and Biophysical Research Communications, 1989
- Functions of Sphingolipids and Sphingolipid Breakdown Products in Cellular RegulationScience, 1989
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- A review of the immunogenic and immuno-modulatory properties of glycosphingolipidsMolecular Immunology, 1984
- The toxicology of a ganglioside extract (Cronassial®)Toxicology Letters, 1983
- The Nomenclature of LipidsEuropean Journal of Biochemistry, 1977
- INFLUENCE OF DOSE AND ROUTE OF ANTIGEN INJECTION ON THE IMMUNOLOGICAL INDUCTION OF T CELLSThe Journal of Experimental Medicine, 1974
- CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*Journal of Neurochemistry, 1963